Halime Kalkavan

7PUBLICATIONS

18CO-AUTHORS

Gene and molecular therapyCancer cell biologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|May 21, 2026

Escape From Synthetic T Cell Activator Tebentafusp by Genomic HLA Loss: A Case Report.

|Feb 25, 2025

BCL-B Promotes Lung Cancer Invasiveness by Direct Inhibition of BOK.

Palaniappan Ramesh, Amal R Al Kadi, Gaurav M Borse

|Jul 12, 2024

Prognostic value of clinical and radiomic parameters in patients with liver metastases from uveal melanoma.

Mael Lever, Simon Bogner, Melina Giousmas

|Jun 05, 2023

Non-lethal outcomes of engaging regulated cell death pathways in cancer.

Halime Kalkavan, Sebastian Rühl, Jeremy J P Shaw

|Oct 03, 2022

Caspase-8 and FADD prevent spontaneous ZBP1 expression and necroptosis.

Diego A Rodriguez, Giovanni Quarato, Swantje Liedmann

|Mar 07, 2018

Regulation of apoptosis by an intrinsically disordered region of Bcl-xL.

Ariele Viacava Follis, Fabien Llambi, Halime Kalkavan

Pageof 2

Frequent Collaborators

Jeremy J P Shaw

Douglas R Green

Stefanie Scheu

Richard W Kriwacki

Diego A Rodriguez

Giovanni Quarato

Jeremy Chase Crawford

1 joint publications

Stephane Pelletier

1 joint publications

Siddharth Balachandran

1 joint publications

Palaniappan Ramesh

Frequent Collaborators

Jeremy J P Shaw

Douglas R Green

Stefanie Scheu

Richard W Kriwacki